Literature DB >> 24751522

miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages.

Ranzun Zhao1, Jian Feng1, Guoxiang He2.   

Abstract

Cholesterol efflux from macrophages is a critical mechanism to prevent the development of atherosclerosis. Although PPARγ is known to be a potent sterol sensor that play a fundamental role in cholesterol metabolism, the potential effects of PPARγ responsive miRNA still need to be revealed. In this study, we found that miR-613 is inversely correlated with LXRα and ABCA1 in PPARγ activated THP-1 cells. PPARγ negatively regulates the expression of miR-613 at transcriptional level, and miR-613 suppressed LXRα and ABCA1 by targeting the 3'-UTR of their mRNAs. Furthermore, downregulation of LXRα and ABCA1 by miR-613 inhibited cholesterol efflux from PPARγ activated THP-1 macrophages. These results revealed an alternative mechanism for PPARγ regulation and provided a potential target for the treatment of cholesterol metabolic diseases.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  ABCA1; Cholesterol efflux; LXRα; MicroRNA-613; PPARγ

Mesh:

Substances:

Year:  2014        PMID: 24751522     DOI: 10.1016/j.bbrc.2014.04.052

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Effects of radiotherapy on nasopharyngeal carcinoma cell invasiveness.

Authors:  Zheng Peng; Tiancai Xu; Xiaofang Liao; Huijuan He; Wansu Xu
Journal:  Tumour Biol       Date:  2015-08-29

Review 2.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

3.  Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit.

Authors:  Seong-Hwan Park; Juil Kim; Mira Yu; Jae-Hong Park; Yong Sik Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 4.  Epigenetic reprogramming in atherosclerosis.

Authors:  Vincenzo Grimaldi; Maria Teresa Vietri; Concetta Schiano; Antonietta Picascia; Maria Rosaria De Pascale; Carmela Fiorito; Amelia Casamassimi; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

5.  Baicalin promotes cholesterol efflux by regulating the expression of SR-BI in macrophages.

Authors:  Renchao Yu; Yuexia Lv; Juanling Wang; Nana Pan; Rui Zhang; Xiaxia Wang; Haichu Yu; Lijuan Tan; Yunhe Zhao; Bo Li
Journal:  Exp Ther Med       Date:  2016-11-08       Impact factor: 2.447

Review 6.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

7.  MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.

Authors:  Duo Li; Dong-Qiong Li; Dan Liu; Xiao-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2016-01-07       Impact factor: 6.730

8.  MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.

Authors:  Xin Fu; Yanfen Cui; Shaobin Yang; Yue Xu; Zicheng Zhang
Journal:  Tumour Biol       Date:  2015-12-02

9.  Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.

Authors:  Jan Novák; Veronika Olejníčková; Nikola Tkáčová; Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 10.  microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.

Authors:  Igor Koturbash; William H Tolleson; Lei Guo; Dianke Yu; Si Chen; Huixiao Hong; William Mattes; Baitang Ning
Journal:  Biomark Med       Date:  2015-10-26       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.